$BAP

BofA Lifts PT on Credicorp (BAP) – Here’s Why

Bank of America raised its price target on Credicorp (BAP) to $408 from $361 and kept a Buy rating, citing a rollover of its valuation basis to 2027 and continued bullishness on Peru banks. Credicorp reported fiscal Q1 2026 net income of S/2,063 million (+16.1% YoY, +30.0% QoQ), with ROE at 21.1%, loan growth and improved asset quality.

Original reporting
Published Jun 24, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 24, 2026, 1:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BofA Lifts PT on Credicorp (BAP) – Here’s Why — source image
Decision brief

The 30-second read

$BAPBullishMed
01

Why it matters

For trading, the key incremental input is the PT increase and maintained Buy rating; the cited fundamentals (net income, ROE, loan growth, NPL and cost of risk) provide the thesis support but are not presented as newly filed disclosures within this article.

02

Market read

A higher analyst PT with a bullish Peru-bank thesis can influence short-term positioning, but the article lacks a new company event beyond the analyst action.

03

What to watch

The article doesn’t quantify valuation multiples or estimate revisions; traders may need to check whether the market already adjusted to the Q1 2026 metrics.

Relevance 5/10Novelty 5/10Timing: post-upgrade/PT change (June 15) as reported June 24

Background

The piece centers on a BofA analyst update to Credicorp (BAP), referencing Q1 2026 results and a valuation-basis rollover to 2027.

Company-level read

Ticker impact

$BAPBullishMedium confidence
Context

BofA lifted Credicorp’s price target to $408 from $361 and kept a Buy rating, citing a valuation-basis rollover to 2027.

Expected impact

Likely modest positive bias for BAP as traders react to the PT change; magnitude depends on how the market already priced the Q1 results.

Evidence & confidence

The article’s actionable catalyst is the analyst PT change (fresh for traders), while the underlying Q1 metrics are presented as context rather than a newly disclosed filing in this text.

Market effects

Supports the read-through that Peru banking credit quality and profitability are improving, which can buoy sentiment for regional financials.

Reinforces bullish positioning on Peru banks via the stated loan growth and NPL/Cost of Risk improvements.

Limited; this is primarily a single-name analyst action with localized emerging-market banking implications.

Counterpoint

PT hikes can lag or overreact to already-known earnings prints; without new guidance or a fresh company catalyst, upside may be capped.

Key entities

  • Credicorp Ltd.

    Peru-focused financial services holding company; subject of the BofA price-target increase and Buy rating.

  • BofA (Bank of America)

    Raised Credicorp’s price target to $408 from $361 and maintained a Buy rating, citing valuation-basis rollover to 2027.

Related articles

$BAPMedAI 8/10

Credicorp Q2 Earnings Call Highlights

Credicorp (NYSE:BAP) discussed Q2 results and outlook on an earnings call, including plans to reassess El Niño-related expected losses by late Q3 or early Q4. Management said full-year 2026 cost of risk should stay within guidance, raised 2026 loan-growth to ~12% and fee-income to high-teens, and reaffirmed 2026 ROE guidance ~19.5%. BCP ROE 29.2%, Mibanco ROE 22.9%, Yape has 16M+ MAUs.

$BAPHighAI 9/10

Bapcor Shares Upgraded, As Price Target Slashed: Value or Trap?

Jefferies upgraded Bapcor (ASX: BAP) to Buy from Hold but cut its price target from A$1.05 to A$0.65. The stock has fallen about 75% over six months and is near A$0.38. Bapcor also secured temporary relief on its net leverage covenant, raising it to 3.5x adjusted EBITDA for test dates through 2026.

$ENPHMedAI 8/10

Stocks making the biggest moves premarket: Ultralife, SK Hynix, Robinhood, Enphase Energy & more

Ultralife shares surged 144% after EnerSys agreed to acquire it for $16 per share, valuing the deal at $320M. Enphase Energy fell 18% due to a revenue decline. PPG Industries rose 6% on record earnings and raised guidance. Robinhood dropped 7% as profit missed expectations. SK Hynix gained 7% on record results. Logitech fell 11% on mixed earnings. Vertiv rallied 16% on strong results and guidance. GE Vernova rose 1% after a $9B acquisition and raised its revenue forecast.

$AMDMed

AMD Stock Jumps 5.45% to $560.26 After $1 Billion Meta Investment

AMD stock rose 5.45% to $560.26 after announcing a $1 billion investment in Meta's equity offering and a partnership with Oracle. The company's Q3 earnings, expected on November 3, are anticipated to show revenue growth of 41% and EPS growth of 62%. Analysts have a consensus 'Strong Buy' rating with an average price target of $653.74.

$VRTHighAI 8/10

Premarket movers: Vertiv, SK Hynix jump; Enphase, NXP slide

Nasdaq futures rose on Wednesday after SK Hynix reported record Q3 2026 results, driving gains in AI-linked semiconductor stocks. SK Hynix shares surged 7.4% with revenue at KRW 104.62 trillion and operating profit up 632% YoY. Vertiv Holdings jumped 15.1% after beating Q3 expectations and raising its 2026 outlook. Enphase Energy fell 15.8% on weak Q3 results and lower Q4 guidance, dragging down SolarEdge Technologies.

$BAMedAI 8/10

Boeing pushes 737 production recovery into 2027 as wing bottleneck persists

Boeing delays 737 production recovery to 2027, citing wing production issues. CEO Kelly Ortberg expects 47 aircraft/month by 2027, with further increases contingent on system readiness. The company delivered 367 737s in 2023 and anticipates fewer than 500 in 2026. Shares fell 9.6% on Tuesday. Boeing expects $3B in free cash flow in 2027, below consensus estimates.